Vista Clinical Research Helps Patients Feel Better

From uterine fibroids to endometriosis, many women suffer for a long time with chronic conditions that don’t get better, despite trying multiple treatments.

Vista Clinical Research can offer these patients new options that may finally help them feel better. As part of the Lexington Medical Center network of care, Vista Clinical Research has expertise in clinical trials involving all areas of women’s health.

A group of uterine fibroid studies is underway at the facility. Women with uterine fibroids often have pain in the abdomen, back or pelvis, and heavy or irregular bleeding. Uterine fibroids typically affect women ages 18 to 49, and up to 60 percent of women will experience them in their lifetime.

Vista Clinical Research is enrolling qualified candidates in several research trials testing a variety of potential medical treatments for uterine fibroids. These investigational treatments may help ease symptoms and prevent the need for surgery.

Clinicians are also enrolling women in an endometriosis trial. Endometriosis is a disorder in which tissue that normally lines the uterus grows outside the uterus. It can cause severe pain, increased menstrual cramps and painful intercourse.

John H. Moore, MD, and Kathryn L. Moore, MD, are the physician investigators who oversee the clinical trials. Both also practice gynecology at Vista Women’s Healthcare, a Lexington Medical Center physician practice.

“When I focus on research, I think about the potential benefits to the patient,” said Dr. John Moore.  “A lot of our patients have exhausted all other options. These methods are sometimes their last chance to achieve significant symptom relief.”

The physicians select the trials in which they want to participate. Each investigational medication has shown potential benefits in earlier studies, but must complete all FDA-mandated trials before being considered approved for widespread use.

In the past, Vista Clinical Research has participated in trials for conditions including migraine headaches, hot flashes, high cholesterol and contraception methods. If a patient qualifies for the trial, there is no cost to participate.

Twitter Digg Delicious Stumbleupon Technorati Facebook Email

No comments yet... Be the first to leave a reply!

Leave a Reply